Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-06-15
Original market date: See footnote 1
2020-06-15
Product name:
ARIDOL
Description:
ORAL INHALATION POWDER CAPSULES OF VARYING STRENGTHS, INHALER INCLUDED
DIN:
02489562
Product Monograph/Veterinary Labelling:
Date:
2019-06-12
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PHARMAXIS LTD
Locked Bag 5015
Frenchs Forest
New South Wales
Australia
2086
Class:
Human
Dosage form(s):
Powder , Kit
Route(s) of administration:
Inhalation
Number of active ingredient(s):
4
Schedule(s):
Prescription Recommended
American Hospital Formulary Service (AHFS): See footnote 3
36:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V04CX OTHER DIAGNOSTIC AGENTS
Active ingredient group (AIG) number:See footnote5
0461510001
| Active ingredient(s) | Strength |
|---|---|
| MANNITOL | 10 MG / CAP |
| MANNITOL | 20 MG / CAP |
| MANNITOL | 40 MG / CAP |
| MANNITOL | 5 MG / CAP |